Lantheus Holdings (LNTH) Total Non-Current Liabilities (2013 - 2026)

Lantheus Holdings (LNTH) reported Total Non-Current Liabilities of $1.1 billion for Q1 2026, up 36.18% year-over-year from $832.8 million in Q1 2025, and little changed quarter-over-quarter from $1.1 billion in Q4 2025.

Lantheus Holdings (LNTH) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 14 years of Total Non-Current Liabilities data on file, last reported at $1.1 billion in Q1 2026.

  • Total Non-Current Liabilities for Q1 2026 came in at $1.1 billion, up 36.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 36.18% YoY), and the FY2025 annual result was $1.1 billion, up 37.18% from the prior year.
  • Total Non-Current Liabilities held at $1.1 billion in Q1 2026 per LNTH's latest filing, from $1.1 billion in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $1.1 billion in Q4 2025 and troughed at $395.8 million in Q1 2022.
  • A 5-year average of $811.8 million and a median of $829.1 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities surged 124.98% in 2022, then fell 4.61% in 2023.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $851.6 million in 2022, then fell by 4.61% to $812.3 million in 2023, then advanced by 2.07% to $829.1 million in 2024, then jumped by 37.18% to $1.1 billion in 2025, then retreated by 0.29% to $1.1 billion in 2026.
  • Business Quant data shows LNTH's Total Non-Current Liabilities at $1.1 billion in Q1 2026, $1.1 billion in Q4 2025, and $1.0 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 18.28 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 11.64 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 599.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 44.12 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 1.24 Bn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 6.26 Bn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 2.44 Bn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 1.13 Bn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 1.81 Bn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.13 Bn
Dec 31, 2025 1.14 Bn
Sep 30, 2025 1.04 Bn
Jun 30, 2025 949.16 Mn
Mar 31, 2025 832.84 Mn
Dec 31, 2024 829.15 Mn
Sep 30, 2024 807.93 Mn
Jun 30, 2024 888.05 Mn
Mar 31, 2024 822.69 Mn
Dec 31, 2023 812.34 Mn
Sep 30, 2023 820.35 Mn
Jun 30, 2023 762.35 Mn
Mar 31, 2023 857.56 Mn
Dec 31, 2022 851.57 Mn
Sep 30, 2022 434.53 Mn
Jun 30, 2022 424.30 Mn
Mar 31, 2022 395.80 Mn
Dec 31, 2021 378.51 Mn
Sep 30, 2021 258.83 Mn
Jun 30, 2021 334.87 Mn